Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 07 2018
revised: 05 10 2018
accepted: 15 10 2018
pubmed: 18 11 2018
medline: 29 5 2020
entrez: 18 11 2018
Statut: ppublish

Résumé

"Core areas" of transmission for bacterial sexually transmitted infections have been identified. However, it is unclear whether core areas apply to viral infections, such as hepatitis C virus (HCV). We used geographic mapping and spatial analysis to identify distinct core areas of HCV infection in British Columbia (BC) using the BC Hepatitis Testers Cohort (BC-HTC), 1990-2013. The BC-HTC includes all BC residents tested for HCV (~1.5 million; 1990-2013). Core HCV infection areas were identified spatially and temporally for five time periods (1990-1993, 1994-1998, 1999-2003, 2004-2008 and 2009-2013) through thematic mapping, Kernel Density Estimation, Hotspot analysis and cluster analysis at the Census dissemination area level in ArcGIS and SatScan. HCV infection core areas were consistently identified. HCV core areas expanded from the downtown of major cities in different regions of BC (Metro Vancouver, Vancouver Island, and Northern BC; 1990-1998), to smaller cities in Metro Vancouver and Interior BC (2000 onwards). Statistically significant clusters, or hotspots, were also observed for downtown Vancouver, Northern BC (Prince George) and Vancouver Island from 1990 to 2008 with expansion to other urban areas in Metro Vancouver from 1990-2013. Statistically significant clusters persisted after adjustment for injection drug use, number of HCV tests, age, sex, material and social deprivation. Persistence of areas with high HCV diagnoses rates in Vancouver and Prince George supports the theory of core areas of HCV transmission. Identification of core areas can inform prevention, care and treatment programme interventions and evaluate their impact over time.

Identifiants

pubmed: 30447122
doi: 10.1111/jvh.13043
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-383

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Zahid A Butt (ZA)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Sunny Mak (S)

British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Dionne Gesink (D)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Mark Gilbert (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Jason Wong (J)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Amanda Yu (A)

British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Stanley Wong (S)

British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Maria Alvarez (M)

British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Mei Chong (M)

British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Jane Buxton (J)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Mark Tyndall (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Mel Krajden (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
BCCDC Public Health Laboratory, Vancouver, British Columbia, Canada.

Naveed Z Janjua (NZ)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH